Peter Powchik, SVP Clin Devel & Reg Affairs at REGENERON PHARMACEUTICALS INC (REGN), sold 30,000 shares at $183.10 ($5.4M) on 2013-01-03, disclosed to the SEC on 2013-01-04.
Scheduled sale ($5.4M) by SVP Clin Devel & Reg Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.82 | 3,584 | $637K | 11.8% |
| 2 | $177.82 | 12,830 | $2.3M | 42.3% |
| 3 | $180.83 | 786 | $142K | 2.6% |
| 4 | $181.51 | 6,200 | $1.1M | 20.9% |
| 5 | $182.29 | 2,300 | $419K | 7.8% |
| 6 | $183.10 | 4,300 |
| $787K |
| 14.6% |
| Total | $179.76 avg | 30,000 | $5.4M | 100% |
| Filing → |
| REGN | SELL | 2014-01-03 | $5.7M | — | Filing → |
| REGN | SELL | 2013-12-20 | $2.5M | — | Filing → |
| REGN | SELL | 2013-12-17 | $2K | — | Filing → |